4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-17-000026
$BHCCIK 0000885590operating
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:09 PM ET
Size
5.1 KB
Accession
0000885590-17-000026
Insider Transaction Report
Form 4
Ross Thomas W. Sr.
Director
Transactions
- Award
Common Stock, no par value
2017-05-05+25,406→ 52,288 total
Footnotes (1)
- [F1]Regular annual Restricted Share Units (RSUs) equal to $250,000 granted to non-employee directors in office on the third trading day following the Annual Meeting of Shareholders based on the closing price of registrant common stock on the date prior to the grant. RSUs represent a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:09 PM ET
- Size
- 5.1 KB